Blog
Ketamine Infusion Therapy Continues to Show Rapid Relief for Depression and Suicidal Thoughts
A newly published JAMA Psychiatry meta-analysis reinforces what many patients and physicians have already witnessed firsthand: intravenous ketamine can produce rapid and meaningful reductions in both depressive symptoms and suicidal ideation — often within hours. The...
Suicidal ideation can be reduced in hours—not weeks.
What New Lancet Research Means for Depression Treatment Major depressive disorder (MDD) remains one of the most challenging mental health conditions to treat—particularly when patients experience suicidal thoughts. One of the greatest limitations in traditional care...
What the VA’s New Psychedelic Trials Mean for Veteran Mental Health—and Why Medical Oversight Matters
As a physician who has spent more than three decades treating patients with complex mental health and pain conditions, I know how urgently we need better solutions—especially for veterans living with PTSD, treatment-resistant depression, and anxiety disorders. That’s...
Microdosing Myths: Why Science Doesn’t Support the Hype
At MiNDSET, we’ve always grounded our care in clinical evidence and medical oversight—not in trends. The recent Neuropharmacology study by Prochazkova and colleagues (2025) underscores why that distinction matters.The Science Speaks: No Real Benefits from Microdosing...
Health Canada Recognizes Ketamine as a National Priority — What This Means for Mental Health Care
A major shift is underway. Health Canada has officially recognized ketamine as a National Priority Drug, marking a turning point in how this powerful therapy is understood and supported across the country. At MiNDSET Integrative Ketamine Care, we see this as more than...
“Are Psychedelics Ready to Stand Alone?”
What a New JAMA Study Reveals — and Why Integration Still Matters** In recent months, conversation around psychedelic medicine has shifted from curiosity to clinical seriousness. The latest editorial in JAMA — “Are Psychedelic Agents Ready for Prime Time as...
Psychiatrist Shortages and the Expanding Role of Primary Care in Depression Treatment
By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care Mental health disorders such as depression and anxiety continue to rise across the United States, yet the number of psychiatrists available to provide specialized care has not kept pace. Today, more...
Integrative Ketamine Care: Advancing Mental Health and Pain Treatment
By Dr. David Caldwell, Founder of MiNDSET Integrative Ketamine Care For decades, patients suffering from treatment-resistant depression (TRD), PTSD, anxiety, and chronic pain have faced a frustrating reality: traditional treatment options often fail to provide relief,...
